In this issue:
Pallidal DBS improves dystonic camptocormia
Sustained benefits after pallidal DBS
Clinical indicators of future Parkinson’s disease
IncobotulinumtoxinA in cervical dystonia
Evidence on BoNT for movement disorders
Surgical targets for dystonic tremor
BoNT-A significantly improves QoL in CD
Acetazolamide for paroxysmal dystonia
EMG improves botulinum toxin response
GPi DBS for DYT1-associated torsion dystonia
Please login below to download this issue (PDF)